(19)
(11) EP 4 815 930 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24816770.2

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
A61K 31/122(2006.01)
A61P 25/08(2006.01)
A61K 31/47(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/47; A61K 31/122; A61P 25/08
 
C-Sets:
  1. A61K 31/47, A61K 2300/00;
  2. A61K 31/122, A61K 2300/00;

(86) International application number:
PCT/EP2024/084345
(87) International publication number:
WO 2025/114605 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 EP 23213736

(71) Applicant: Katholieke Universiteit Leuven
3000 Leuven (BE)

(72) Inventors:
  • CAMMUE, Bruno
    3000 Leuven (BE)
  • DE WITTE, Peter
    3000 Leuven (BE)
  • LAGAE, Lieven
    3000 Leuven (BE)
  • NY, Annelii
    3000 Leuven (BE)
  • THEVISSEN, Karin
    3000 Leuven (BE)

(74) Representative: Arnold & Siedsma 
Bezuidenhoutseweg 57
2594 AC The Hague
2594 AC The Hague (NL)

   


(54) ANTI-SEIZURE COMBINATION THERAPY